|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/00 | (2006.01) |
| A61K 9/20 | (2006.01) | ||
| A61K 9/70 | (2006.01) | ||
| A61K 31/137 | (2006.01) |
| (11) | Number of the document | 2465492 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12155251.7 |
| Date of filing the European patent application | 2008-10-09 | |
| (97) | Date of publication of the European application | 2012-06-20 |
| (45) | Date of publication and mention of the grant of the patent | 2015-07-01 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 979482 P | 2007-10-12 | US |
| (72) |
Ruegger, Colleen, US
Ambühl, Michael, CH
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | Compositions comprising sphingosine I phosphate (sip) receptor modulators |
| Compositions comprising sphingosine I phosphate (sip) receptor modulators |